ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001720007

Dexcel Pharma Technologies Ltd.

CIK 0001720007 Name as filed on the most recent filing

Filed as Dexcel Pharma Technologies Ltd. (20)

40 transaction lines · from 20 filings · filed 2018-04-04 to 2022-11-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2022-11-10 Roivant Sciences Ltd.
ROIV 		P, Open-market purchase 4,000,000 acquired 5.00 20,000,000.00 Form 4, filing 0001104659-22-117847
2022-04-25 Roivant Sciences Ltd.
ROIV 		P, Open-market purchase 8,600 acquired 3.91 33,635.46 Form 4, filing 0001104659-22-049930
2022-04-22 Roivant Sciences Ltd.
ROIV 		P, Open-market purchase 31,685 acquired 3.83 121,318.70 Form 4, filing 0001104659-22-049930
2021-06-03 Protalix BioTherapeutics, Inc.
PLX 		S, Open-market sale 857,506 disposed 2.25 1,932,304.02 Form 4, filing 0001104659-21-076488
2021-06-02 Protalix BioTherapeutics, Inc.
PLX 		S, Open-market sale 61,211 disposed 2.56 156,553.25 Form 4, filing 0001104659-21-076488
2020-02-04 Intec Pharma Ltd.
NTEC 		S, Open-market sale 110,000 disposed 0.29 31,900.00 Form 4, filing 0001104659-20-010828
2020-02-03 Intec Pharma Ltd.
NTEC 		S, Open-market sale 80,000 disposed 0.32 25,440.00 Form 4, filing 0001104659-20-010828
2020-01-31 Intec Pharma Ltd.
NTEC 		S, Open-market sale 725,951 disposed 0.31 224,318.86 Form 4, filing 0001104659-20-010828
2019-06-19 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 4,957 acquired 8.17 40,495.22 Form 4, filing 0001144204-19-031542
2019-06-18 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,706 acquired 8.21 55,060.95 Form 4, filing 0001144204-19-031542
2019-06-17 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,541 acquired 8.53 55,824.82 Form 4, filing 0001144204-19-031542
2019-06-14 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,144 acquired 7.91 56,514.04 Form 4, filing 0001144204-19-031054
2019-06-13 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,367 acquired 7.95 58,542.60 Form 4, filing 0001144204-19-031054
2019-06-12 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,500 acquired 8.30 62,244.00 Form 4, filing 0001144204-19-031054
2019-06-11 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,189 acquired 8.58 61,693.84 Form 4, filing 0001144204-19-030612
2019-06-10 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,500 acquired 8.35 62,594.25 Form 4, filing 0001144204-19-030612
2019-06-07 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,649 acquired 7.96 52,959.28 Form 4, filing 0001144204-19-030612
2019-06-06 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,082 acquired 8.00 56,621.30 Form 4, filing 0001144204-19-030138
2019-06-05 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,540 acquired 8.02 52,418.10 Form 4, filing 0001144204-19-030138
2019-06-04 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,500 acquired 7.59 56,910.75 Form 4, filing 0001144204-19-030138
2019-06-04 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 2,424,242 acquired 8.25 19,999,996.50 Form 4, filing 0001144204-19-030140
2019-06-03 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,424 acquired 7.71 41,814.70 Form 4, filing 0001144204-19-029540
2019-05-31 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,071 acquired 7.70 39,042.14 Form 4, filing 0001144204-19-029540
2019-05-30 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,951 acquired 7.97 55,417.54 Form 4, filing 0001144204-19-029540
2019-05-30 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 300 acquired 8.91 2,671.98 Form 4, filing 0001144204-19-029540
2019-05-29 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,882 acquired 7.55 51,983.19 Form 4, filing 0001144204-19-028688
2019-05-28 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 3,807 acquired 7.68 29,244.61 Form 4, filing 0001144204-19-028688
2019-05-24 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 3,796 acquired 7.70 29,233.38 Form 4, filing 0001144204-19-028688
2019-05-23 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 4,802 acquired 7.76 37,252.00 Form 4, filing 0001144204-19-028456
2019-05-22 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,033 acquired 8.06 40,557.93 Form 4, filing 0001144204-19-028456
2019-05-21 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 9,995 acquired 8.52 85,108.42 Form 4, filing 0001144204-19-027995
2019-05-20 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 8,285 acquired 7.98 66,141.64 Form 4, filing 0001144204-19-027731
2019-05-20 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 1,715 acquired 8.39 14,383.19 Form 4, filing 0001144204-19-027731
2019-05-17 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,200 acquired 7.36 45,641.30 Form 4, filing 0001144204-19-027306
2019-05-16 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,408 acquired 6.79 36,718.16 Form 4, filing 0001144204-19-027306
2019-03-18 Axovant Sciences Ltd.
AXON 		P, Open-market purchase 6,666,667 acquired 1.50 10,000,000.50 Form 4, filing 0001144204-19-014887
2018-12-18 Axovant Sciences Ltd.
AXON 		P, Open-market purchase 10,000,000 acquired 1.00 10,000,000.00 Form 4, filing 0001144204-18-065508
2018-10-01 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 2,678,571 acquired 14.00 37,499,994.00 Form 4, filing 0001144204-18-052388
2018-06-05 Axovant Sciences Ltd.
AXON 		P, Open-market purchase 14,285,714 acquired 1.75 24,999,999.50 Form 4, filing 0001144204-18-033168
2018-04-02 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 1,110,015 acquired 20.27 22,500,004.05 Form 4, filing 0001144204-18-019287

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Dexcel Pharma Technologies Ltd., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001720007

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.